EGAIN Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EGAIN Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | $15.59M | Sep 13, 2018 |
| FY2018 | Mar 31, 2018 | $15.75M | Sep 13, 2018 |
| FY2018 | Dec 31, 2017 | $15.40M | Sep 13, 2018 |
| FY2018 | Sep 30, 2017 | $14.58M | Sep 13, 2018 |
| FY2018 | Jun 30, 2017 | $14.62M | Sep 13, 2018 |
| FY2018 | Mar 31, 2017 | $13.85M | Sep 13, 2018 |
| FY2018 | Dec 31, 2016 | $15.00M | Sep 13, 2018 |
| FY2018 | Sep 30, 2016 | $14.75M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $17.62M | Sep 26, 2017 |
| FY2017 | Mar 31, 2016 | $16.29M | Sep 26, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $88.43M | Sep 12, 2025 |
| FY2024 | Jun 30, 2024 | $22.46M | Sep 12, 2024 |
| FY2024 | Mar 31, 2024 | $22.35M | Sep 12, 2024 |
| FY2024 | Dec 31, 2023 | $23.82M | Sep 12, 2024 |
| FY2024 | Sep 30, 2023 | $24.18M | Sep 12, 2024 |
| FY2024 | Jun 30, 2023 | $24.64M | Sep 12, 2024 |
| FY2024 | Mar 31, 2023 | $23.01M | Sep 12, 2024 |
| FY2024 | Dec 31, 2022 | $25.60M | Sep 12, 2024 |
| FY2024 | Sep 30, 2022 | $24.76M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $23.50M | Sep 14, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $62.01M | Sep 12, 2025 |
| FY2024 | Jun 30, 2024 | $15.56M | Sep 12, 2024 |
| FY2024 | Mar 31, 2024 | $15.49M | Sep 12, 2024 |
| FY2024 | Dec 31, 2023 | $16.83M | Sep 12, 2024 |
| FY2024 | Sep 30, 2023 | $17.34M | Sep 12, 2024 |
| FY2024 | Jun 30, 2023 | $17.95M | Sep 12, 2024 |
| FY2024 | Mar 31, 2023 | $15.42M | Sep 12, 2024 |
| FY2024 | Dec 31, 2022 | $18.85M | Sep 12, 2024 |
| FY2024 | Sep 30, 2022 | $18.48M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $16.90M | Sep 14, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $32.25M | Sep 12, 2025 |
| FY2024 | Jun 30, 2024 | $1.51M | Sep 12, 2024 |
| FY2024 | Mar 31, 2024 | $1.49M | Sep 12, 2024 |
| FY2024 | Dec 31, 2023 | $2.19M | Sep 12, 2024 |
| FY2024 | Sep 30, 2023 | $2.60M | Sep 12, 2024 |
| FY2024 | Jun 30, 2023 | $2.60M | Sep 12, 2024 |
| FY2024 | Mar 31, 2023 | ($372.0K) | Sep 12, 2024 |
| FY2024 | Dec 31, 2022 | ($104.0K) | Sep 12, 2024 |
| FY2024 | Sep 30, 2022 | ($16.0K) | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | ($1.55M) | Sep 14, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $4.43M | Sep 12, 2025 |
| FY2024 | Jun 30, 2024 | $1.19M | Sep 12, 2024 |
| FY2024 | Mar 31, 2024 | $938.0K | Sep 12, 2024 |
| FY2024 | Dec 31, 2023 | $2.43M | Sep 12, 2024 |
| FY2024 | Sep 30, 2023 | $1.42M | Sep 12, 2024 |
| FY2024 | Jun 30, 2023 | $2.36M | Sep 12, 2024 |
| FY2024 | Mar 31, 2023 | ($512.0K) | Sep 12, 2024 |
| FY2024 | Dec 31, 2022 | $213.0K | Sep 12, 2024 |
| FY2024 | Sep 30, 2022 | ($670.0K) | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | ($1.72M) | Sep 14, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $29.60M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $26.63M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $27.30M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $24.39M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $17.93M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $16.64M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $14.37M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $14.71M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $13.75M | Sep 13, 2018 |
| FY2018 | Jun 30, 2016 | $16.06M | Sep 13, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $5.26M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $12.45M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $4.62M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $8.12M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $13.86M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $14.06M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $6.95M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $6.59M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $5.40M | Sep 13, 2018 |
| FY2018 | Jun 30, 2016 | $1.87M | Sep 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $565.0K | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $198.0K | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $288.0K | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $628.0K | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $402.0K | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $514.0K | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $398.0K | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $137.0K | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $492.0K | Sep 13, 2018 |
| FY2018 | Jun 30, 2016 | $547.0K | Sep 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $148.01M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $127.85M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $130.12M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $126.01M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $114.56M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $93.71M | Sep 10, 2021 |
| FY2020 | Jul 1, 2019 | $78.13M | Sep 11, 2020 |
| FY2020 | Jun 30, 2019 | $73.75M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $39.62M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $39.75M | Sep 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $67.27M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $69.36M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $68.42M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $69.15M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $68.50M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $59.06M | Sep 10, 2021 |
| FY2020 | Jul 1, 2019 | $53.83M | Sep 11, 2020 |
| FY2020 | Jun 30, 2019 | $49.45M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $48.34M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $49.37M | Sep 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $80.73M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $58.50M | Sep 12, 2025 |
| FY2025 | Jun 30, 2023 | $61.70M | Sep 12, 2025 |
| FY2024 | Jun 30, 2022 | $56.86M | Sep 12, 2024 |
| FY2023 | Jun 30, 2021 | $46.06M | Sep 14, 2023 |
| FY2022 | Jun 30, 2020 | $34.64M | Sep 13, 2022 |
| FY2021 | Jun 30, 2019 | $24.31M | Sep 10, 2021 |
| FY2020 | Jun 30, 2018 | ($8.71M) | Sep 11, 2020 |
| FY2019 | Jun 30, 2017 | ($9.62M) | Sep 12, 2019 |
| FY2018 | Jun 30, 2016 | ($4.28M) | Sep 13, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.19M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $13.19M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $13.19M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $13.19M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $13.19M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $13.19M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $13.19M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $13.19M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $13.19M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | $13.19M | Sep 26, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($291.41M) | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | ($323.66M) | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | ($331.44M) | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | ($333.55M) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | ($331.11M) | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | ($338.07M) | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | ($345.28M) | Sep 11, 2020 |
| FY2019 | Jul 2, 2018 | ($349.44M) | Sep 12, 2019 |
| FY2019 | Jun 30, 2018 | ($353.26M) | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | ($351.27M) | Sep 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $62.91M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | $70.00M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | $73.20M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | $72.17M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $63.23M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | $46.61M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | $31.86M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | $11.50M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | $10.63M | Sep 13, 2018 |
| FY2018 | Jun 30, 2016 | $11.78M | Sep 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Jun 30, 2016 | $20.22M | Sep 13, 2016 |
| FY2015 | Jun 30, 2015 | $18.26M | Sep 14, 2015 |
| FY2015 | Jun 30, 2014 | $5.00M | Sep 14, 2015 |
| FY2013 | Jun 30, 2013 | $4.67M | Sep 23, 2013 |
| FY2012 | Jun 30, 2012 | $3.33M | Sep 25, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Sep 12, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Sep 12, 2024 |
| FY2024 | Mar 31, 2024 | 0 | Sep 12, 2024 |
| FY2024 | Dec 31, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Sep 12, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 14, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 1 | Sep 12, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Sep 12, 2024 |
| FY2024 | Mar 31, 2024 | 0 | Sep 12, 2024 |
| FY2024 | Dec 31, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Sep 30, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Jun 30, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Mar 31, 2023 | 0 | Sep 12, 2024 |
| FY2024 | Dec 31, 2022 | 0 | Sep 12, 2024 |
| FY2024 | Sep 30, 2022 | 0 | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 14, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 27.08M | Sep 12, 2025 |
| FY2025 | Jun 30, 2024 | 29.16M | Sep 12, 2025 |
| FY2024 | Jun 30, 2023 | 31.48M | Sep 12, 2024 |
| FY2023 | Jun 30, 2022 | 31.93M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | 31.23M | Sep 13, 2022 |
| FY2021 | Jun 30, 2020 | 30.82M | Sep 10, 2021 |
| FY2020 | Jun 30, 2019 | 30.48M | Sep 11, 2020 |
| FY2019 | Jun 30, 2018 | 27.67M | Sep 12, 2019 |
| FY2018 | Jun 30, 2017 | 27.13M | Sep 13, 2018 |
| FY2017 | Jun 30, 2016 | 27.11M | Sep 26, 2017 |